Cellogen Therapeutics announced that it has received around $2 million in a round of funding on January 17, 2024. The transaction included participation from new investor, NATCO Pharma Limited.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,016 INR | -1.75% | +0.83% | +25.23% |
Apr. 09 | Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit | MT |
Mar. 27 | NATCO Pharma Limited Announces Board Appointments | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.23% | 2.22B | |
+28.50% | 662B | |
+22.23% | 546B | |
-4.93% | 359B | |
+16.97% | 323B | |
+4.08% | 289B | |
+13.68% | 234B | |
+3.84% | 198B | |
-10.35% | 194B | |
+3.98% | 167B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- Cellogen Therapeutics announced that it has received $2 million in funding from NATCO Pharma Limited